Arrowhead Pharmaceuticals (ARWR) Stock: Here’s What You Need To Know

Arrowhead Pharmaceuticals (NASDAQ:ARWR) On Monday, Arrowhead Pharmaceuticals stock closed down by 1.58%, even though it announced that it had completely finished the deal with Amgen. The deal between Arrowhead and Amgen had finally closed today. Investors weren’t too enthusiastic, as the stock closed lower instead of heading higher. This news is definitely good news, and … Read more